Thomas P Richardson
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$4.0MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $4.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 26, 2026 | NIH | SBIR Phase II Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy | $1.5M | PLUMERIA THERAPEUTICS, INC. |
| Aug 1, 2025 | NIH | SBIR Phase II Laboratory Developed Test (LDT) to Support Clinical Evaluation of a Drug for Painful Diabetic Neuropathy | $1.5M | PLUMERIA THERAPEUTICS, INC. |
| Sep 21, 2021 | NIH | SBIR Phase I Chemokine-receptor profiling for painful diabetic neuropathy in biological samples from human clinical trials | $700K | PLUMERIA THERAPEUTICS, INC. |
| Jan 18, 2019 | NIH | SBIR Phase I Chemokine-receptor expression profiling in biological samples from human clinical trials | $55K | PLUMERIA THERAPEUTICS, INC. |
| Aug 21, 2018 | NIH | SBIR Phase I Chemokine-receptor expression profiling in biological samples from human clinical trials | $225K | PLUMERIA THERAPEUTICS, INC. |
Peer ranks
Federal funding#426
Awards as PI#470
Patents#505
Companies
- PLUMERIA THERAPEUTICS, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.